Rome RM - Search Results

1

Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.

Bisseling KC, Bekkers RL, Rome RM, Quinn MA. Bisseling KC, et al. Among authors: rome rm. Gynecol Oncol. 2007 Dec;107(3):424-30. doi: 10.1016/j.ygyno.2007.07.062. Epub 2007 Aug 20. Gynecol Oncol. 2007. PMID: 17707895 Review.

2

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Ostör AG, Duncan A, Quinn M, Rome R. Ostör AG, et al. Gynecol Oncol. 2000 Nov;79(2):207-10. doi: 10.1006/gyno.2000.5957. Gynecol Oncol. 2000. PMID: 11063645

3

Microinvasive adenocarcinoma of the cervix: a clinicopathologic study of 77 women.

Ostör A, Rome R, Quinn M. Ostör A, et al. Obstet Gynecol. 1997 Jan;89(1):88-93. doi: 10.1016/s0029-7844(96)00386-9. Obstet Gynecol. 1997. PMID: 8990445

4

Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer.

Zusterzeel PL, Bekkers RL, Hendriks JC, Neesham DN, Rome RM, Quinn MA. Zusterzeel PL, et al. Among authors: rome rm. Acta Obstet Gynecol Scand. 2008;87(2):240-6. doi: 10.1080/00016340701876163. Acta Obstet Gynecol Scand. 2008. PMID: 18231895 Free article.

5

A prospective study of inhibin in granulosa cell tumors of the ovary.

Jobling T, Mamers P, Healy DL, MacLachlan V, Burger HG, Quinn M, Rome R, Day AJ. Jobling T, et al. Gynecol Oncol. 1994 Nov;55(2):285-9. doi: 10.1006/gyno.1994.1291. Gynecol Oncol. 1994. PMID: 7959297 Clinical Trial.

6

Steroid receptors and ovarian tumors: variation within primary tumors and between primary tumors and metastases.

Quinn MA, Rome RM, Cauchi M, Fortune DW. Quinn MA, et al. Among authors: rome rm. Gynecol Oncol. 1988 Nov;31(3):424-9. doi: 10.1016/s0090-8258(88)80026-x. Gynecol Oncol. 1988. PMID: 3181813

7

Ovarian cancer: patterns of care in Victoria during 1993-1995.

Grossi M, Quinn MA, Thursfield VJ, Francis PA, Rome RM, Planner RS, Giles GG. Grossi M, et al. Among authors: rome rm. Med J Aust. 2002 Jul 1;177(1):11-6. doi: 10.5694/j.1326-5377.2002.tb04616.x. Med J Aust. 2002. PMID: 12088472

8

Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.

Cade TJ, Quinn MA, Rome RM, Polyakov A. Cade TJ, et al. Among authors: rome rm. Aust N Z J Obstet Gynaecol. 2014 Oct;54(5):453-6. doi: 10.1111/ajo.12245. Aust N Z J Obstet Gynaecol. 2014. PMID: 25287561

9

VIN 3: a clinicopathologic review.

McNally OM, Mulvany NJ, Pagano R, Quinn MA, Rome RM. McNally OM, et al. Among authors: rome rm. Int J Gynecol Cancer. 2002 Sep-Oct;12(5):490-5. doi: 10.1046/j.1525-1438.2002.01140.x. Int J Gynecol Cancer. 2002. PMID: 12366668

10

Long-term outcomes after progestogen treatment for early endometrial cancer.

Cade TJ, Quinn MA, Rome RM, Neesham D. Cade TJ, et al. Among authors: rome rm. Aust N Z J Obstet Gynaecol. 2013 Dec;53(6):566-70. doi: 10.1111/ajo.12142. Epub 2013 Oct 19. Aust N Z J Obstet Gynaecol. 2013. PMID: 24138444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page